A Multicenter, Randomised, Double-Blind Study Comparing De Novo Once Monthly and Once Every 2 Week Darbepoetin Alfa Dosing for the Correction of Anemia in Subjects With Chronic Kidney Disease Not Receiving Dialysis
A Multicenter, Randomised, Double-Blind Study Comparing De Novo Once Monthly and Once Every 2 Week Darbepoetin Alfa Dosing for the Correction of Anemia in Subjects With Chronic Kidney Disease Not Receiving Dialysis
The purpose of this study is to determine whether once monthly (QM) dosing of darbepoetin alfa is non-inferior to that of once every 2 week (Q2W) dosing of darbepoetin alfa for the correction of anemia in patients with Chronic Kidney Disease who are not receiving dialysis.
Inclusion Criteria:
Exclusion Criteria:
Liège, 4000, Belgium
Praha 4 - Nusle, 140 00, Czechia
Ã…rhus, 8200, Denmark
Düsseldorf, 40210, Germany
Albano Laziale RM, 00041, Italy
Setúbal, 2910-446, Portugal
Krgujevac, 34000, Serbia
Jaén, AndalucÃ-a 23007, Spain